CEO says AstraZeneca didn’t overpromise on COVID-19 vaccine supplies

Published: Updated:

AstraZeneca’s chief executive said on Friday the drugmaker had not overpromised on its ability to supply COVID-19 vaccines around the world, as he defended big cuts in deliveries that prompted a lawsuit by the European Union.

Pascal Soriot told a media briefing that the company did its best to deliver as much as it could to the EU.

For more coronavirus news, visit our dedicated page.

“We never overpromised, we communicated what we thought we would achieve at the time,” he said.

For all the latest headlines follow our Google News channel online or via the app.

Read more:

AstraZeneca Q1 COVID-19 vaccine revenue hits $275 million

EU sues AstraZeneca for not respecting coronavirus vaccine supply contract

EU legal action against AstraZeneca won’t help get more vaccines: German Minister

Top Content Trending